ArticleInternational journal of nanomedicine2025

Human Mesenchymal Stem Cell-Derived Exosomes as Engineering Vehicles of Daunorubicin for Targeted c-Mpl+ AML Therapy.

Chunmou Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.